Advocacy Works for Ophthalmic ASCs - Scorecard - MDSpire

Advocacy Works for Ophthalmic ASCs

In partnership with members and industry stakeholders, OOSS supports strategies that enhance patient and physician experience, drive operational performance, and enable long-term growth.

  • By

  • Diane Blanck

  • Michael A. Romansky, JD

  • July 1, 2026

  • 3 min

Share

Clinical Scorecard: Advocacy Works for Ophthalmic ASCs

At a Glance

CategoryDetail
ConditionOphthalmic Surgery
Key MechanismsAdvocacy for Medicare reimbursement and operational excellence
Target PopulationOphthalmic ASCs and their patients
Care SettingOutpatient Ophthalmic Surgery Centers

Key Highlights

  • OOSS advocates for Medicare facility reimbursement for ophthalmic services
  • Promotes fair and sustainable facility payment policies
  • Supports strategies to enhance patient and physician experience
  • Membership provides access to resources for ASC leaders
  • OOSS has been active for over 44 years in advocating for ophthalmic ASCs

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients undergoing ophthalmic procedures in ASCs

          Focus on enhancing patient care and operational performance

          Clinical Best Practices

          • Adhere to the highest standards of patient care and safety
          • Engage in advocacy to influence regulatory policies
          • Utilize OOSS resources for operational improvement

          Related Resources & Content

          Original Source(s)

          Advocacy Works for Ophthalmic ASCs

          • by Diane Blanck, Michael A. Romansky, JD

          • July 1, 2026

          Related Content

          High-Tech Contact Lenses

          From the promise of tailored drug delivery to augmented reality and continuous health monitoring, there have been numerous avenues of research investigating the high-tech contact lenses of the future.

          Diabetic retinopathy and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: a systematic review and meta-analysis

          Meta-analysis of the association between retinopathy and the risk of stroke